MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

23 Nov 2020 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed media release titled ‘Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1765.60
Dr. Reddys Labs. 1184.40
Cipla 1303.85
Lupin 1989.25
Zydus Lifesciences 1116.10
View more..